Delivery Order SPE2DR25D3017-SPE2DR26F3EL4
- Not listed
- The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Duloxetine HCL DR 30 mg capsules (1,000 units) valued at $6,441.21 with a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Duloxetine is a...
- The Defense Logistics Agency awarded a $4,657.95 delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Duloxetine HCL DR 30 mg on December 5, 2025, with an ultimate completion date of December 8, 2025. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count) with a ceiling value of $4,654.16. This is a firm fixed price delivery order with an ultimate completion date of November 21, 2025, and no set-aside designation was utilized. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Duloxetine is a serotonin-norepinephrine...
- The Defense Logistics Agency awarded a delivery order valued at $19,803.22 to AmerisourceBergen Drug Corp for 1,000 capsules of Duloxetine HCL DR 20 mg on November 26, 2025, with completion scheduled for November 28, 2025. The award is a firm fixed-price, non-set-aside contract with performance originating from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Duloxetine is a serotonin-norepinephrine reuptake inhibitor commonly used to treat depression, anxiety, and chronic...
- The Defense Logistics Agency awarded a delivery order valued at $2,244.93 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units). This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Duloxetine is a serotonin-norepinephrine reuptake...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Duloxetine HCL DR 20 mg capsules (60-count) with a ceiling value of $2,298.60. This contract award, issued on September 29, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. The award was competitively procured without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Duloxetine HCL DR 30 mg capsules (1,000 units) with a ceiling value of $3,233.57. This is a firm fixed price delivery order with no set-aside designation, utilizing open competition. The contract is scheduled for ultimate completion by November 13, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,133.54 to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 20 mg capsules (1,000 count). This non-compete, firm fixed-price delivery order is set to be completed by October 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger indefinite delivery contract (IDC) vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Duloxetine HCL DR 20 mg capsules (1,000 count) with a ceiling value of $1,016.71. This firm fixed-price delivery order, which is not set-aside, represents a competitively awarded pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Duloxetine HCL (delayed-release) 30 mg capsules in a quantity of 1,000 units, with a contract ceiling value of $11,209.41. This non-set-aside delivery order employs firm fixed-price terms and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. The award represents a routine pharmaceutical...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3EL4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Duloxetine HCL (delayed-release) 30 mg capsules in a quantity of 1,000 units, valued at $1,711.00. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by December 10, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Duloxetine is a serotonin-norepinephrine reuptake inhibitor commonly used to treat depression, anxiety, and chronic pain conditions, making it a critical pharmaceutical supply for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of federal contract awards predominantly with DLA and its Medical Supply Chain, positioning the company as a key provider for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/8/25 |